Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Andres Andreo-Vidal"'
Autor:
Kyle J. Mamounis, Maria Luiza Caldas Nogueira, Daniela Priscila Marchi Salvador, Andres Andreo-Vidal, Antonio Sanchez-Amat, Victor L. Davidson
Publikováno v:
Molecules, Vol 27, Iss 15, p 4726 (2022)
The Pseudoalteromonas luteoviolacea strain CPMOR-1 expresses a flavin adenine dinucleotide (FAD)-dependent L-amino acid oxidase (LAAO) with broad substrate specificity. Steady-state kinetic analysis of its reactivity towards the 20 proteinogenic amin
Externí odkaz:
https://doaj.org/article/957482ba0bfa455fab9d96e5aa6a540c
Autor:
Oleksandr Yushchuk, Andres Andreo-Vidal, Giorgia Letizia Marcone, Mervyn Bibb, Flavia Marinelli, Elisa Binda
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Genome sequencing has revealed that Nonomuraea spp. represent a still largely unexplored source of specialized metabolites. Nonomuraea gerenzanensis ATCC 39727 is the most studied representative species since it produces the glycopeptide antibiotic (
Externí odkaz:
https://doaj.org/article/f450723e765745f78b31faae223455dc
Autor:
Oleksandr, Yushchuk, Natalia M, Vior, Andres, Andreo-Vidal, Francesca, Berini, Christian, Rückert, Tobias, Busche, Elisa, Binda, Jörn, Kalinowski, Andrew W, Truman, Flavia, Marinelli
Publikováno v:
ACS Chemical Biology
Glycopeptide antibiotics (GPAs) are last defense line drugs against multidrug-resistant Gram-positive pathogens. Natural GPAs teicoplanin and vancomycin, as well as semisynthetic oritavancin, telavancin, and dalbavancin, are currently approved for cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4a49f01dd60c571f799fd4656c2f3776
https://pubmed.ncbi.nlm.nih.gov/33913701
https://pubmed.ncbi.nlm.nih.gov/33913701
Autor:
Natalia M. Vior, Oleksandr Yushchuk, Andres Andreo-Vidal, Andrew W. Truman, Flavia Marinelli, Elisa Binda, Christian Rückert, Francesca Berini, Tobias Busche, Jörn Kalinowski
Glycopeptide antibiotics (GPAs) are last defense line drugs against multidrug-resistant Gram-positive pathogens. Natural GPAs teicoplanin and vancomycin, as well as semisynthetic oritavancin, telavancin, and dalbavancin, are currently approved for cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24ff5e95427c1374366f38fede355dfa
http://hdl.handle.net/11383/2112667
http://hdl.handle.net/11383/2112667
Autor:
Andres Andreo-Vidal, Dante Avalos, Kyle J. Mamounis, Jonatan C. Campillo-Brocal, Esha Sehanobish, Erik T. Yukl, Antonio Sanchez-Amat, Victor L. Davidson
Publikováno v:
Biochemistry. 57:1155-1165
Glycine oxidase from Pseudoalteromonas luteoviolacea (PlGoxA) is a cysteine tryptophylquinone (CTQ)-dependent enzyme. Sequence and phylogenetic analysis place it in a newly designated subgroup (Group IID) of a recently identified family of LodA-like
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a850e86cbe61b80ab1288e3beeb918d8
https://doi.org/10.1021/acs.biochem.8b00009
https://doi.org/10.1021/acs.biochem.8b00009
Autor:
Oleksandr Yushchuk, Andres Andreo-Vidal, Mervyn J. Bibb, Giorgia Letizia Marcone, Flavia Marinelli, Elisa Binda
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Frontiers in Microbiology
Frontiers in Microbiology
Genome sequencing has revealed that Nonomuraea spp. represent a still largely unexplored source of specialized metabolites. Nonomuraea gerenzanensis ATCC 39727 is the most studied representative species since it produces the glycopeptide antibiotic (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e7d75911fa3702ec51d2853bc86dcd5
https://pubmed.ncbi.nlm.nih.gov/32038594
https://pubmed.ncbi.nlm.nih.gov/32038594
Publikováno v:
Marine Drugs
Volume 16
Issue 12
Marine Drugs, Vol 16, Iss 12, p 499 (2018)
Volume 16
Issue 12
Marine Drugs, Vol 16, Iss 12, p 499 (2018)
The marine environment is a rich source of antimicrobial compounds with promising pharmaceutical and biotechnological applications. The Pseudoalteromonas genus harbors one of the highest proportions of bacterial species producing antimicrobial molecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c327c8ce9d41f7dc4ab2b475fd369b23
Publikováno v:
Antibiotics, Vol 12, Iss 4, p 641 (2023)
Teicoplanin and A40926 (natural precursor of dalbavancin) are clinically relevant glycopeptide antibiotics (GPAs) produced by Actinoplanes teichomyceticus NRRL B-16726 and Nonomuraea gerenzanensis ATCC 39727. Their biosynthetic enzymes are coded with
Externí odkaz:
https://doaj.org/article/2996665436a54ce5b87ee5421213ea7f
Publikováno v:
Antibiotics, Vol 10, Iss 12, p 1533 (2021)
The spread of antimicrobial resistance (AMR) creates a challenge for global health security, rendering many previously successful classes of antibiotics useless. Unfortunately, this also includes glycopeptide antibiotics (GPAs), such as vancomycin an
Externí odkaz:
https://doaj.org/article/1482fb7f89fb40ec97c01c50e7d1fbd1
Publikováno v:
Marine Drugs, Vol 16, Iss 12, p 499 (2018)
The marine environment is a rich source of antimicrobial compounds with promising pharmaceutical and biotechnological applications. The Pseudoalteromonas genus harbors one of the highest proportions of bacterial species producing antimicrobial molecu
Externí odkaz:
https://doaj.org/article/ce8fa7ad60bb479992175e7822310f85